Topics

Glioblastoma | Treatment | Targeted therapy | Idasanutlin

Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Idasanutlin

Wick W, Lanz LM, Wick A, Harting I, Dettmer S, Suwala AK, Ketter R, Tabatabai G, Seliger C, Glas M, Burger MC, Timmer M, Ringel FA, Mildenberger I, Schulz-Schaeffer WJ, Winkler F, König L, Herold-Mende C, Eisenmenger A, Pfister SM, Renovanz M, Bendszus M, Sahm F, Platten M, Kessler T.
Molecularly matched targeted therapies plus radiotherapy in glioblastoma: the phase 1/2a N²M² umbrella trial.
Nat Med. 2025 Sep 5. doi: 10.1038/s41591-025-03928-9. PMID: 40913172. Interventional study. ˍ